Table 5 Number of serious adverse events and occurrence relative to bronchoscopic thermal vapour ablation treatment within 6 months of treatment
EventTotal observed≤48 h>48 h ≤30 days>30 days ≤90 days>90 days ≤180 days
End-stage COPD10010
COPD exacerbation90252
Gastro-oesophageal reflux10010
Haemoptysis30111
Pneumonia60411
Post-treatment inflammation reaction10100
Respiratory tract infection50302
Right upper quadrant abdominal pain10001
Urinary retention10001
Ventricular fibrillation10010
Total events29011108

  • Data are presented as n. COPD: chronic obstructive pulmonary disease.